Short Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Declines By 44.3%

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) saw a large decrease in short interest during the month of August. As of August 31st, there was short interest totaling 5,794 shares, a decrease of 44.3% from the August 15th total of 10,400 shares. Based on an average daily volume of 12,937 shares, the days-to-cover ratio is currently 0.4 days. Approximately 3.4% of the company’s stock are short sold.

ProShares UltraShort Nasdaq Biotechnology Stock Performance

NASDAQ:BIS opened at $12.04 on Thursday. ProShares UltraShort Nasdaq Biotechnology has a fifty-two week low of $10.51 and a fifty-two week high of $28.20. The firm has a 50-day simple moving average of $12.42 and a two-hundred day simple moving average of $15.33.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.